ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Charity LifeArc sells rights to Keytruda for more than $1bn pharmaceutical-technology
May 22, 2019UK-based medical research charity LifeArc has sold its royalty interest in Merck’s Keytruda (pembrolizumab) for $1.297bn to the European subsidiary of Canada Pension Plan Investment Board (CPPIB).
Pharma Sources Insight July 2025
